Select a medication above to begin.
Quillivant XR
methylphenidate
Black Box Warnings .
Abuse, Misuse, and Addiction
CNS stimulants have high potential for abuse and misuse, can lead to substance use disorder, incl. addiction; misuse and abuse can result in overdose and death, risk incr. w/ higher doses or unapproved admin. methods; assess risk for abuse, misuse, and addiction before prescribing and throughout tx; educate pts and families about risks and proper drug storage and disposal; monitor frequently for s/sx of abuse, misuse, and addiction during tx
Adult Dosing .
Dosage forms: ER SUSP (20% IR/80% ER): 25 mg per 5 mL
Special Note
- [strength clarification]
- Info: all strengths expressed as methylphenidate hydrochloride
- [formulation clarification]
- Info: not interchangeable w/ other methylphenidate products; do not substitute on a mg to mg basis; retitrate if switching between products
ADHD
- [20-60 mg PO qam]
- Start: 20 mg PO qam, may incr. by 10-20 mg/day q7 days; Max: 60 mg/day; Info: duration 12h
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: ER SUSP (20% IR/80% ER): 25 mg per 5 mL
Special Note
- [strength clarification]
- Info: all strengths expressed as methylphenidate hydrochloride
- [formulation clarification]
- Info: not interchangeable w/ other methylphenidate products; do not substitute on a mg to mg basis; retitrate if switching between products
ADHD
- [6 yo and older]
- Dose: 20-60 mg PO qam; Start: 20 mg PO qam, may incr. by 10-20 mg/day q7 days; Max: 60 mg/day; Info: duration 12h
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]